Assertio Therapeutics, Inc. (ASRT): Price and Financial Metrics

Assertio Therapeutics, Inc. (ASRT): $0.81

0.02 (+2.00%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add ASRT to Watchlist
Sign Up

ASRT Price/Volume Stats

Current price $0.81 52-week high $8.01
Prev. close $0.79 52-week low $0.77
Day low $0.78 Volume 502,000
Day high $0.82 Avg. volume 996,281
50-day MA $0.93 Dividend yield N/A
200-day MA $3.11 Market Cap 76.21M

ASRT Stock Price Chart Interactive Chart >

ASRT POWR Grades

  • Value is the dimension where ASRT ranks best; there it ranks ahead of 98.27% of US stocks.
  • ASRT's strongest trending metric is Quality; it's been moving down over the last 26 weeks.
  • ASRT's current lowest rank is in the Stability metric (where it is better than 3.59% of US stocks).

ASRT Stock Summary

  • With a one year PEG ratio of 0.08, ASSERTIO HOLDINGS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 1.41% of US stocks.
  • Price to trailing twelve month operating cash flow for ASRT is currently 1.36, higher than only 3.77% of US stocks with positive operating cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, ASSERTIO HOLDINGS INC is reporting a growth rate of -671%; that's higher than merely 1.94% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to ASSERTIO HOLDINGS INC are AHCO, ADV, BTU, CNX, and MGY.
  • ASRT's SEC filings can be seen here. And to visit ASSERTIO HOLDINGS INC's official web site, go to www.assertiotx.com.

ASRT Valuation Summary

  • ASRT's EV/EBIT ratio is -0.3; this is 102.05% lower than that of the median Healthcare stock.
  • Over the past 243 months, ASRT's EV/EBIT ratio has gone up 15.4.

Below are key valuation metrics over time for ASRT.

Stock Date P/S P/B P/E EV/EBIT
ASRT 2023-12-29 0.6 0.5 -0.5 -0.3
ASRT 2023-12-28 0.6 0.5 -0.6 -0.3
ASRT 2023-12-27 0.6 0.5 -0.6 -0.3
ASRT 2023-12-26 0.6 0.6 -0.6 -0.3
ASRT 2023-12-22 0.6 0.5 -0.6 -0.3
ASRT 2023-12-21 0.6 0.5 -0.6 -0.3

ASRT Growth Metrics

    Its year over year net income to common stockholders growth rate is now at 104.99%.
  • The 3 year net income to common stockholders growth rate now stands at 128.87%.
  • Its 2 year net income to common stockholders growth rate is now at 102%.
Over the past 49 months, ASRT's revenue has gone down $224,369,000.

The table below shows ASRT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 139.209 56.032 25.678
2022-06-30 130.469 50.641 25.241
2022-03-31 120.711 37.175 3.238
2021-12-31 111.014 5.523 -1.281
2021-09-30 107.86 -4.59 -30.241
2021-06-30 116.953 -23.675 -44.5

ASRT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ASRT has a Quality Grade of C, ranking ahead of 35.61% of graded US stocks.
  • ASRT's asset turnover comes in at 0.367 -- ranking 129th of 680 Pharmaceutical Products stocks.
  • NOVN, ARWR, and RIOT are the stocks whose asset turnover ratios are most correlated with ASRT.

The table below shows ASRT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.367 0.819 -1.136
2021-03-31 0.343 0.800 -1.673
2020-12-31 0.354 0.813 -0.761
2020-09-30 0.380 0.884 -1.944
2020-06-30 0.337 0.927 -1.098
2020-03-31 0.332 0.957 -0.485

ASRT Price Target

For more insight on analysts targets of ASRT, see our ASRT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.20 Average Broker Recommendation 1.5 (Moderate Buy)

Assertio Therapeutics, Inc. (ASRT) Company Bio


Assertio Therapeutics, Inc. (formerly DepoMed) develops products for pain and other central nervous system conditions in the United States. The company was founded in 1995 and is focused in Newark, California.


ASRT Latest News Stream


Event/Time News Detail
Loading, please wait...

ASRT Latest Social Stream


Loading social stream, please wait...

View Full ASRT Social Stream

Latest ASRT News From Around the Web

Below are the latest news stories about ASSERTIO HOLDINGS INC that investors may wish to consider to help them evaluate ASRT as an investment opportunity.

Pre-Surge Penny Picks: 3 Stocks to Buy Before They Boom

Investing in penny stocks can be a great way to unlock gains from your portfolio.

Matthew Farley on InvestorPlace | December 25, 2023

With 51% ownership of the shares, Assertio Holdings, Inc. (NASDAQ:ASRT) is heavily dominated by institutional owners

Key Insights Institutions' substantial holdings in Assertio Holdings implies that they have significant influence over...

Yahoo | November 17, 2023

Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors

LAKE FOREST, Ill., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that make a difference in the lives of patients, announced today that Sravan Emany has been appointed to the Company’s Board of Directors. As part of the appointment, Assertio has expanded its board to seven seats. Mr. Emany currently serves as the Chief Financial Offic

Yahoo | November 14, 2023

Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2023 Earnings Call Transcript

Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2023 Earnings Call Transcript November 8, 2023 Assertio Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $0.23. Operator: Good morning and welcome to the Assertio Holdings Inc. Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. After today’s presentation, there […]

Yahoo | November 10, 2023

Astra Space (ASTR) Stock Spikes 82% on Take-Private Proposal

Astra Space stock is taking off on Thursday as investors react to a take-private offer for ASTR shares from the company's founders.

William White on InvestorPlace | November 9, 2023

Read More 'ASRT' Stories Here

ASRT Price Returns

1-mo -7.37%
3-mo -33.61%
6-mo -75.38%
1-year -83.99%
3-year -77.99%
5-year -95.25%
YTD -24.30%
2023 -75.12%
2022 97.25%
2021 52.40%
2020 -71.39%
2019 -65.37%

Continue Researching ASRT

Here are a few links from around the web to help you further your research on Assertio Therapeutics Inc's stock as an investment opportunity:

Assertio Therapeutics Inc (ASRT) Stock Price | Nasdaq
Assertio Therapeutics Inc (ASRT) Stock Quote, History and News - Yahoo Finance
Assertio Therapeutics Inc (ASRT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!